Your journey to wellness, simplified in three clear steps.
Check EligibilityAnswer a few clinical and lifestyle questions so our team can understand your needs. It's completely private, quick and easy, and helps us match you with the right treatment path.
What we ask about:
Our licensed prescribers assess your health profile, confirm your eligibility, and determine the ideal GLP-1 treatment and dosage. If anything's unclear, we'll reach out with a few follow-up questions—or a quick video call.
What happens:
Once approved, your medication is dispatched from our UK pharmacy in plain packaging directly to your door. This is just the beginning of your Arc journey—a 12-month transformation program designed to help you achieve lasting results.
What to expect:
Ready to start your Arc journey?
Check Your EligibilityHave a question? We're here. NuVina isn't just software—it's a team.
Clinical guidance on dosage, timing, or changes
Email us anytime
Nuvina@NorthParkPharmacy.onmicrosoft.com
How fast will I see results?
Most people start noticing changes within the first few weeks, with appetite reduction often being the first sign. Full results typically develop over 3-6 months as part of your Arc journey.
Are GLP-1s safe?
Yes, GLP-1 medications have been extensively studied and are approved for weight management. Our prescribers carefully assess your suitability and monitor your progress throughout your journey.
What if I have side effects?
Our team is here to support you. Most side effects are mild and temporary. We'll help you manage any concerns and adjust your treatment if needed.
Can I stop anytime?
Yes, you can stop at any time. However, we recommend completing your full Arc journey for the best long-term results. Our team will help you make the right decision for your health.
How do I know this is right for me?
Our assessment process helps determine if GLP-1 treatment is suitable for you. We consider your health history, goals, and current situation to ensure the best possible outcome.
Take two minutes now. Start your Arc today.